Litcius/Paper detail

Overexpression of long non-coding RNA MCM3AP-AS1 in breast cancer tissues compared to adjacent non-tumour tissues

Atousa Riahi, M Hosseinpour-Feizi, Ali Rajabi, Moloud Akbarzadeh, Vahid Montazeri, Reza Safaralizadeh

2020British Journal of Biomedical Science20 citationsDOI

Abstract

Background Altered expression of several long non-coding RNAs (lncRNAs) has been described in numerous malignancies, including breast cancer, and some may have a role in carcinogenesis. We hypothesised differences in the expression of lncRNA MCM3AP-AS1 in breast cancer tissues compared to nearby healthy tissues and potential links with clinical features.Methods We tested our hypothesis in 102 pairs of breast cancer tumours and adjacent non-tumour tissues from female patients. After RNA extraction, cDNA synthesis was performed for all specimens. The differential gene expression was assessed using Quantitative Real-Time PCR Technique.Results There was a significant overexpression of the lncRNAs in tumour tissues as compared with their adjacent non-tumour tissues (P < 0.001). Expression was significantly linked with the tumour oestrogen receptor expression (P = 0.023) and tumour progesterone receptor expression (P < 0.001). ROC analysis showed an AUC of 0.67 (95% CI 0.60–0.75) (P < 0.001) with sensitivity and specificity of 58% and 76%, respectivelyConclusion The lncRNA MCM3AP-AS1 may be a novel breast cancer lncRNA with high expression levels in breast cancer patients’ tissue. Further investigations are needed to confirm its uses as a potential molecular marker and therapeutic target.

Topics & Concepts

Breast cancerCarcinogenesisLong non-coding RNACancer researchCancerRNABiologyGene expressionRNA extractionComplementary DNAPathologyGeneOncologyMedicineGeneticsCancer-related molecular mechanisms researchKruppel-like factors researchMedicinal Plant Pharmacodynamics Research